{"issuance_frequency":"","notes_translated":{"fr":"Santé Canada diffuse la présente ligne directrice applicable aux essais cliniques sur le diabète de type 2 dans le but de clarifier l'interprétation des Lignes directrices de pratique clinique de l'Association canadienne du diabète (LDPC-ACD)Note de bas de page1 en ce qui concerne les demandes d'essai clinique en vertu de la partie C, titre 5, du Règlement sur les aliments et drogues.","en":"Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"680ba36e-36dd-4a91-a135-5fdf69a4d552","metadata_created":"2021-06-02T18:42:09.585671","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-02T18:42:09.585677","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-02","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["lignes directrices pour l'industrie","normes","essais cliniques sur le diabète de type 2","lignes directrices de pratique clinique de l'Association canadienne du diabète","CDA-CPG","Règlement sur les aliments et drogues"],"en":["guidance for industry","standards","clinical trials in type 2 diabetes","Canadian Diabetes Association Clinical Practice Guidelines","CDA-CPG","Food and drug Regulations"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice : Normes applicables aux essais cliniques sur le diabète de type 2 au Canada","en":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"680ba36e-36dd-4a91-a135-5fdf69a4d552","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ee60f220-f0a9-43b9-b82c-9f06d7458bd8","related_relationship":"","name_translated":{"fr":"Ligne directrice : Normes applicables aux essais cliniques sur le diabète de type 2 au Canada","en":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada","language":["en"],"created":"2021-06-02T18:42:09.681043","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/guidance-industry-standards-clinical-trials-type-2-diabetes-canada.html#a11","last_modified":null,"position":0,"revision_id":"254c4d09-b09e-4c2b-9618-0f64cde08276","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"680ba36e-36dd-4a91-a135-5fdf69a4d552","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fbd84f3e-1f44-4c71-9e6a-6623a5fee04a","related_relationship":"","name_translated":{"fr":"Ligne directrice : Normes applicables aux essais cliniques sur le diabète de type 2 au Canada","en":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada","language":["fr"],"created":"2021-06-02T18:42:09.681049","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/ligne-directrice-normes-applicables-essais-cliniques-diabete-type-2-canada.html#a11","last_modified":null,"position":1,"revision_id":"254c4d09-b09e-4c2b-9618-0f64cde08276","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2007-09-04 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"680ba36e-36dd-4a91-a135-5fdf69a4d552","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada","revision_id":"254c4d09-b09e-4c2b-9618-0f64cde08276"}